Osanai Yuu | Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
スポンサーリンク
概要
- OSANAI Yuuの詳細を見る
- 同名の論文著者
- Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical Universityの論文著者
関連著者
-
ISHIKAWA Masaaki
Department of Pharmacology and Toxicology, Cancer Research Institute, Tohoku Pharmaceutical Universi
-
OSANAI Yuu
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
Osanai Yuu
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Kanno Syu-ichi
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Kanno Syu-ichi
東北薬科大学癌研究所
-
Kanno Syu-ichi
東北薬科大学 薬物治療学教室
-
Kanno Syu-ichi
Department Of Pharmacology And Toxicology Cancer Research Institute Tohoku Pharmaceutical University
-
Ishikawa Masaaki
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Ishikawa Masaaki
Department Of Pharmacology And Toxicology Cancer Research Institute Tohoku Pharmaceutical University
-
Ishikawa Masaaki
Department Of Pharmacology And Toxicology Cancer Research Institute Tohoku College Of Pharmacy
-
Ishikawa Masaaki
Dep. Of Clinical Pharmacotheraputics Tohoku Pharmaceutical Univ. Jpn
-
UJIBE Mayuko
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
Ujibe Mayuko
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
KANNO Syu-ichi
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
Kimura Katsuhiko
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Koiwai Kimiko
Department Of Pharmacology And Toxicology Cancer Research Institute Tohoku Pharmaceutical University
-
OHTAKE Takaharu
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
Ohtake Takaharu
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Uwai Kohji
Department Of Pharmacology Tohoku Pharmaceutical University
-
Takeshita Mitsuhiro
Department Of Pharmacology Tohoku Pharmaceutical University
-
KITAJIMA Yasue
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
KAKUTA Mai
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
KURAUCHI Kaori
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
Kakuta Mai
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Kitajima Yasue
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
TAKESHITA Mituhiro
Department of Pharmaceutics, Tohoku Pharmaceutical University
-
UWAI Kouji
Department of Pharmaceutics, Tohoku Pharmaceutical University
-
HIURA Takako
Department of Pharmacology and Toxicology, Cancer Research Institute, Tohoku Pharmaceutical Universi
-
Hiura Takako
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
KOIWAI Kimiko
Department of Pharmacology and Toxicology, Cancer Research Institute, Tohoku College of Pharmacy
-
TOMIZAWA Ayako
Department of Pharmacology and Toxicology, Cancer Research Institute, Tohoku Pharmaceutical Universi
-
SHOUJI Ai
Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University
-
KANNO Syuichi
Department of Pharmacology and Toxicology, Cancer Research Institute, Tohoku Pharmaceutical Universi
-
Kanno Syuichi
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Shouji Ai
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
Tomizawa Ayako
Department Of Pharmacology And Toxicology Cancer Research Institute Tohoku Pharmaceutical University
-
Koiwai Kimiko
Department Of Clinical Pharmacotherapeutics Tohoku Pharmaceutical University
-
SATOH Susumu
Department of Pharmacology and Pharmacotherapy, Nihon Pharmaceutical University
-
Satoh S
Department Of Pharmacology And Pharmacotherapy Nihon Pharmaceutical University
-
Satoh Susumu
Nagasaki Institute Of Applied Science
-
UWAI Koji
Department of Pharmaceutics, Tohoku Pharmaceutical University
-
TAKESHITA Mitsuhiro
Department of Phamacology and Pharmacy, Cancer Research Institute
-
OHTAKE Takaharu
Tohoku Employee's Pension Welfare Hospital
-
OSANAI Yu
Department of Pharmacology and Toxicology, Cancer Research Institute, Tohoku Pharmaceutical Universi
-
UWAI Kohji
Tohoku Employees' Pension Welfare Hospital
-
TAKESHITA Mitsuhiro
Tohoku Employees' Pension Welfare Hospital
-
KIMURA Katsuhiko
Tohoku Employees' Pension Welfare Hospital
-
Uwai Koji
Department Of Pharmaceutics Tohoku Pharmaceutical University
-
Satoh Susumu
Department Of Neurosurgery Yamagata Prefectural Central Hospital
-
Takeshita Mitsuhiro
Tohoku College Of Pharmacy
-
Kimura Katsuhiko
Tohoku College Of Pharmacy
-
Kimura Katsuhiko
Department Of Biology Fauculty Of Science Osaka City University
著作論文
- Costunolide-Induced Apoptosis Is Caused by Receptor-Mediated Pathway and Inhibition of Telomerase Activity in NALM-6 Cells(Pharmacology)
- Trimidox-Induced Apoptosis Is Mediated Through Induction of p53 in NALM-6 Cells
- Resistance to Ara-C Up-Regulates the Activation of NF-κB, Telomerase Activity and Fas Expression in NALM-6 Cells(Pharmacology)
- Inhibitory Effect of Trimidox on Lipopolysaccharide-Induced Nitric Oxide Production in RAW 264.7 Macrophages
- Preventive Effect of Trimidox on Oxidative Stress in U937 Cell Line(Pharmacology)
- Melatonin Protects on Toxicity by Acetaminophen But Not on Pharmacological Effects in Mice(Pharmacology)
- Octylcaffeate Induced Apoptosis in Human Leukemia U937 Cells(Biopharmacy)
- Inhibitory Effects of Naringenin on Tumor Growth in Human Cancer Cell Lines and Sarcoma S-180-Implanted Mice(Pharmacology)
- Inhibitory Effect of Octylcaffeate on Lipopolysaccharide-Induced Nitric Oxide Production in Macrophages